Síndrome de POEMS: reporte de un caso

Bardwick, 1980, Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome Report on two cases and a review of the literature, Medicine (Baltimore), 59, 311, 10.1097/00005792-198007000-00006 Suichi, 2019, Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey, Neurology, 93, e975, 10.1212/WNL.0000000000008062 Keddie, 2018, POEMS syndrome, Curr Opin Neurol, 31, 551, 10.1097/WCO.0000000000000610 Straume, 2006, Bevacizumab therapy for POEMS syndrome, Blood, 107, 4972, 10.1182/blood-2005-12-5045 Abe, 2008, Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome, Blood, 112, 836, 10.1182/blood-2007-12-126979 Nasu, 2012, Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy, J Neurol Neurosurg Psychiatry, 83, 476, 10.1136/jnnp-2011-301706 Li, 2017, Diagnostic challenges in POEMS syndrome presenting with polyneuropathy: A case series, J Neurol Sci, 378, 170, 10.1016/j.jns.2017.05.019 Dispenzieri, 2019, POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management, Am J Hematol, 94, 812, 10.1002/ajh.25495 Karam, 2015, Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome, Neurology, 84, 1981, 10.1212/WNL.0000000000001565 Nozza, 2017, POEMS syndrome: An update, Mediterr J Hematol Infect Dis, 9, e2017051, 10.4084/mjhid.2017.051 Mauermann, 2018, The peripheral neuropathies of POEMS syndrome and Castleman disease, Hematol Oncol Clin North Am, 32, 153, 10.1016/j.hoc.2017.09.012 Liu, 2015, Motor nerve conduction study and muscle strength in newly diagnosed POEMS syndrome, Muscle Nerve, 51, 19, 10.1002/mus.24267 Marinho, 2015, Cutaneous manifestations in POEMS syndrome: Case report and review, Case Rep Dermatol, 7, 61, 10.1159/000381302 Jeunon, 2011, Glomeruloid hemangioma in POEMS syndrome: A report on two cases and a review of the literature, An Bras Dermatol, 86, 1167, 10.1590/S0365-05962011000600016 Cui, 2014, Papilloedema is an independent prognostic factor for POEMS syndrome, J Neurol, 261, 60, 10.1007/s00415-013-7143-4 Brown, 2019, POEMS syndrome: Clinical update, J Neurol, 266, 268, 10.1007/s00415-018-9110-6 Haider, 2013, Atypical B12 deficiency with nonresolving paraesthesia, Case Rep Oncol Med, 2013, 823842 Drappatz, 2004, Neurologic complications of plasma cell disorders, Clin Lymphoma, 5, 163, 10.3816/CLM.2004.n.022 Keddie, 2018, POEMS neuropathy: Optimising diagnosis and management, Pract Neurol, 18, 278, 10.1136/practneurol-2017-001792 Nobile-Orazio, 2017, Advances in the treatment of paraproteinemic neuropathy, Curr Treat Options Neurol, 19, 43, 10.1007/s11940-017-0479-9 Nozza, 2017, Lenalidomide and dexamethasone in patients with POEMS syndrome: Results of a prospective, open-label trial, Br J Haematol, 179, 748, 10.1111/bjh.14966 Kourelis, 2017, Validation of a prognostic score for patients with POEMS syndrome: A mayo clinic cohort, Leukemia, 31, 1251, 10.1038/leu.2017.68 Wang, 2017, Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome, Leukemia, 31, 100, 10.1038/leu.2016.168 Misawa, 2015, Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: Retrospective cohort study, BMJ Open, 5, e009157, 10.1136/bmjopen-2015-009157